Gene · 6249
Papers2,568
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,568
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility. | Hum Genomics | 2022 | 36424660 | PubTator, text mining | PubMed |
| Study of an RNA-Focused DNA-Encoded Library Informs Design of a Degrader of a r(CUG) Repeat Expansion. | J Am Chem Soc | 2022 | 36399603 | PubTator, text mining | PubMed |
| RET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy. | Cancers (Basel) | 2022 | 36358717 | PubTator, text mining | PubMed |
| Desmin intermediate filaments and tubulin detyrosination stabilize growing microtubules in the cardiomyocyte. | Basic Res Cardiol | 2022 | 36326891 | PubTator, text mining | PubMed |
| IQCN disruption causes fertilization failure and male infertility due to manchette assembly defect. | EMBO Mol Med | 2022 | 36321563 | PubTator, text mining | PubMed |
| Comprehensive analysis of the expression and prognosis for IQ motif-containing GTPase-activating proteins in hepatocellular carcinoma. | BMC Cancer | 2022 | 36320006 | PubTator, text mining | PubMed |
| Modified Albumin-Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy. | Cancers (Basel) | 2022 | 36291867 | PubTator, text mining | PubMed |
| Label-Free Quantitative Proteomics Analysis of Adriamycin Selected Multidrug Resistant Human Lung Cancer Cells. | Biomolecules | 2022 | 36291610 | PubTator, text mining | PubMed |
| Smp24, a Scorpion-Venom Peptide, Exhibits Potent Antitumor Effects against Hepatoma HepG2 Cells via Multi-Mechanisms In Vivo and In Vitro. | Toxins (Basel) | 2022 | 36287985 | PubTator, text mining | PubMed |
| Expression of AKT1 Related with Clinicopathological Parameters in Clear Cell Renal Cell Carcinoma. | Curr Issues Mol Biol | 2022 | 36286049 | PubTator, text mining | PubMed |
| The autophagy inducer SMER28 attenuates microtubule dynamics mediating neuroprotection. | Sci Rep | 2022 | 36284196 | PubTator, text mining | PubMed |
| Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12. | Nat Commun | 2022 | 36271053 | PubTator, text mining | PubMed |
| Chemoproteomic Approach for the Quantitative Identification of Arsenic-Binding Proteins. | Chem Res Toxicol | 2022 | 36269594 | PubTator, text mining | PubMed |
| A novel chromatin regulator-related immune checkpoint related gene prognostic signature and potential candidate drugs for endometrial cancer patients. | Hereditas | 2022 | 36253800 | PubTator, text mining | PubMed |
| Trim69 is a microtubule regulator that acts as a pantropic viral inhibitor. | Proc Natl Acad Sci U S A | 2022 | 36251989 | PubTator, text mining | PubMed |
| Nanoparticle-based modulation of CD4+ T cell effector and helper functions enhances adoptive immunotherapy. | Nat Commun | 2022 | 36241639 | PubTator, text mining | PubMed |
| Regulation of CHK1 inhibitor resistance by a c-Rel and USP1 dependent pathway. | Biochem J | 2022 | 36240066 | PubTator, text mining | PubMed |
| Chemical Proteomics Reveals Protein Tyrosination Extends Beyond the Alpha-Tubulins in Human Cells. | Chembiochem | 2022 | 36218090 | PubTator, text mining | PubMed |
| The Autophagy Receptor TAX1BP1 (T6BP) improves antigen presentation by MHC-II molecules. | EMBO Rep | 2022 | 36215666 | PubTator, text mining | PubMed |
| Tension of plus-end tracking protein Clip170 confers directionality and aggressiveness during breast cancer migration. | Cell Death Dis | 2022 | 36209218 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6249/papers?page=18